biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
11:35 One-time gene-editing shot for inherited eye clouding cleared for testing✦05:33 An AI reading of a routine eye photo may hint at Alzheimer's risk years early✦23:36 Vitamin A molecule helps shape sharp central vision before birth, lab finds✦23:34 Exercising only on weekends tied to similar health gains, studies find✦23:33 Pfizer to use an AI 'scientist' across parts of its drug research✦17:34 Unusually low or high hemoglobin on routine blood tests tied to dementia✦17:33 Three-drug mix kept advanced melanoma in check far longer in a trial✦05:37 Some breast cancer patients skipped chemo; 92% stayed disease-free 5 years✦11:35 One-time gene-editing shot for inherited eye clouding cleared for testing✦05:33 An AI reading of a routine eye photo may hint at Alzheimer's risk years early✦23:36 Vitamin A molecule helps shape sharp central vision before birth, lab finds✦23:34 Exercising only on weekends tied to similar health gains, studies find✦23:33 Pfizer to use an AI 'scientist' across parts of its drug research✦17:34 Unusually low or high hemoglobin on routine blood tests tied to dementia✦17:33 Three-drug mix kept advanced melanoma in check far longer in a trial✦05:37 Some breast cancer patients skipped chemo; 92% stayed disease-free 5 years
← All story threadsSTORY THREAD

One-shot gene editing for inherited corneal disease.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 1, 2026
    FDA CLEARS A FIRST HUMAN TRIAL; NO RESULTS YETFDA lets human trial begin

    One-time gene-editing shot for inherited eye clouding cleared for testing

    US regulators let start-up GenEditBio begin a first trial of a single eye injection that edits a faulty gene behind a group of inherited corneal diseases. No results have been reported yet.